Acta Scientific Pharmacology

Review Article Volume 1 Issue 9

An Understanding about COVID-19 during the Days of Lockdown

Asha PK*

New Horizon College of Engineering, Bangalore, India

*Corresponding Author: Asha PK, New Horizon College of Engineering, Bangalore, India

Received: May 01, 2020; Published: August 18, 2020

×

Abstract

The pandemic caused due to the novel corona virus has halted the world. In the late months of 2019 few cases of severe pneumonia has been reported in Wuhan in China. Studies revealed it to be caused due to a virus, which is novel and temporarily named as acute respiratory syndrome coronavirus 2. This unexpected outbreak of the pandemic has shaken the entire part of the human population, business, and industries, factories without any difference between rich or poor. This has essentially compartmentalized or categorized the human mankind into immune or healthy ones, susceptible, infected and recovered classes. The non-pharmaceutical intervention to control over the spreading of the contagious disease like lockdown, washing hands, masks and social distancing have made a great control over this disease. The purpose of this review is to quantify how much these non-pharmaceutical intervention has reigned the virus spread.

Keywords: COVID-19; Lockdown; Virus; SARS-CoV-2

×

References

  1. Shereen MA., et al. “COVID-19 infection: origin, transmission, and characteristics of human coronaviruses”. Journal of Advanced Research (2020).
  2. Cui J., et al. “Origin and evolution of pathogenic coronaviruses”. Nature reviews Microbiology 17.3 (2019): 181-192.
  3. Lai CC., et al. “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges”. International Journal of Antimicrobial Agents (2020): 105924.
  4. World Health Organization. “Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020 (No. WHO/COVID-19/laboratory/2020.4)”. World Health Organization (2020).
  5. Rahman A and Sarkar A. “Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013–2018”. American Journal of Public Health 109.9 (2019): 1288-1293.
  6. Wang C., et al. “A novel coronavirus outbreak of global health concern”. The Lancet 395.10223 (2020): 470-473.
  7. Wu JT., et al. “Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study”. The Lancet 395.10225 (2020): 689-697.
  8. Zheng YY., et al. “COVID-19 and the cardiovascular system”. Nature Reviews Cardiology 17.5 (2020): 259-260.
  9. Rothan HA and Byrareddy SN. “The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak”. Journal of autoimmunity (2020): 102433.
  10. Menni C., et al. “Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection”. medRxiv (2020).
  11. Chu DK., et al. “Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia”. Clinical chemistry 66.4 (2020): 549-555.
  12. Yam WC., et al. “Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus”. Journal of Clinical Microbiology 41.10 (2003): 4521-4524.
  13. Corman VM., et al. “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR”. Eurosurveillance 25.3 (2020): 2000045.
  14. Riou J and Althaus CL. “Pattern of early human to human transmission of Wuhan 2019-n CoV”. bioRxiv (2020).
  15. Li Q., et al. “Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia”. New England Journal of Medicine (2020).
  16. Cai J., et al. “Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020”. Emerging Infectious Diseases 26.6 (2020).
  17. Roy S. “COVID-19 pandemic: Impact of lockdown, contact and non-contact transmissions on infection dynamics”. medRxiv (2020).
  18. Tesarik J. “After corona: there is life after the pandemic”. Reproductive BioMedicine Online (2020).
×

Citation

Citation: Asha PK. “An Understanding about COVID-19 during the Days of Lockdown".Acta Scientific Pharmacology 1.9 (2020): 21-24.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is September 30, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US